Vol 4 Issue 3

CELL AND GENE THERAPY INSIGHTS

March 2018 Issue

Vol 4 Issue 3

Download PDF

Featuring

Issue Spotlight: Supply Chain Management Part 1: Getting it Right from the Start
Other articles
Webinars

SPOTLIGHT

Supply Chain Management Part 1: Getting it Right from the Start
Jean Stanton
Guest Editor:
Jean Stanton, Director, Commercial Apheresis Operations at Janssen Pharmaceutical companies of Johnson & Johnson

Expert Insight

Making the grade: untangling the myths of raw materials used for the manufacture of cell- & gene-based medicinal products

Making the grade: untangling the myths of raw materials used for the manufacture of cell- & gene-based medicinal products

Sarah Robinson, Scott R Burger, Christopher Bravery
6 April 2018
Read
Innovation in Management as a Tool for Accelerated Translation of Advanced Therapies

Innovation in Management as a Tool for Accelerated Translation of Advanced Therapies

Nicholas Medcalf
5 April 2018
Read

Innovator Insight

Addressing Particulates, Extractables & Leachables & the Quality of Single-Use Systems for Cell & Gene Therapy Manufacturing

Addressing Particulates, Extractables & Leachables & the Quality of Single-Use Systems for Cell & Gene Therapy Manufacturing

Dominic Clarke
16 April 2018
Read
The Evolution of Product Transfer and Labeling in Cellular Therapy

The Evolution of Product Transfer and Labeling in Cellular Therapy

Lizette Caballero
16 April 2018
Read

Journal articles

Interview

Optimizing the Cell Collection Network to Support the Commercialization of Cell & Gene Therapies

Optimizing the Cell Collection Network to Support the Commercialization of Cell & Gene Therapies

Amy Hines, Kimberly Kasow, Sandra Hoffmann
6 June 2018
Read
Perspectives on the use of ancillary materials for cell and gene therapies

Perspectives on the use of ancillary materials for cell and gene therapies

Shirley Bartido
3 May 2018
Read
Understanding the Role of Critical Quality Attributes along the Commercialization Pathway

Understanding the Role of Critical Quality Attributes along the Commercialization Pathway

Anna Gilbert
6 April 2018
Read

Commercial Insights

Cell & Gene Therapy Commercial Insight – March 2018

Cell & Gene Therapy Commercial Insight – March 2018

Mark Curtis, Richard Philipson
16 April 2018
Read

Webinars